Six US Senators have approached the Department of Justice and the Federal Trade Commission expressing concern over the proposed merger between Pfizer and AstraZeneca, despite the fact that a formal merger deal has yet to be made.
Reports say the senators, all Democrats, are urging the regulators to conduct a strict …read more
Source: Global Competition Law Blogs